Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Yue-Yun Lai

Efficacy, Safety and Pharmacokinetics of Subcutaneous Azacitidine in Chinese Patients With Higher Risk Myelodysplastic Syndromes: Results From a Multicenter, Single-Arm, Open-Label Phase 2 Study

Asia-Pacific Journal of Clinical Oncology

Medicine

Oncology

2017

English

Related publications

A 5-Day Regimen of Azacitidine for Lower-Risk Myelodysplastic Syndromes (RA or RARS): A Prospective Single-Arm Phase 2 Trial

English

Pharmacokinetics and Safety of Apremilast in Pediatric Patients With Moderate to Severe Plaque Psoriasis: Results From a Phase 2 Open-Label Study

Journal of the American Academy of Dermatology

Dermatology

2020

English

Efficacy and Safety of Privigen®in Patients With Chronic Inflammatory Demyelinating Polyneuropathy: Results of a Prospective, Single-Arm, Open-Label Phase III Study (The PRIMA Study)

Journal of the Peripheral Nervous System

English

Pharmacokinetics, Antiviral Activity, and Safety of Rilpivirine in Pregnant Women With HIV-1 Infection: Results of a Phase 3b, Multicenter, Open-Label Study

Infectious Diseases and Therapy

Infectious Diseases

Microbiology

2018

English

Umbralisib Monotherapy Demonstrates Efficacy and Safety in Patients With Relapsed/Refractory Marginal Zone Lymphoma: A Multicenter, Open-Label, Registration Directed Phase 2 Study

Hematological Oncology

English

A Phase II, Single-Arm, Open-Label, Multicenter Study to Evaluate the Efficacy and Safety of P276-00, a Cyclin-Dependent Kinase Inhibitor, in Patients With Relapsed or Refractory Mantle Cell Lymphoma

Clinical Lymphoma, Myeloma and Leukemia

English

Efficacy, Safety and Population Pharmacokinetics of Sapropterin in PKU Patients <4 Years: Results From the SPARK Open-Label, Multicentre, Randomized Phase IIIb Trial

Orphanet Journal of Rare Diseases

English

Safety and Efficacy of Azacitidine in the Treatment of Elderly Patients With Myelodysplastic Syndrome

Clinical Interventions in Aging

English

Safety and Efficacy of Regorafenib in Patients With Treatment-Refractory Metastatic Colorectal Cancer in Turkey: The Single-Arm, Open-Label REGARD Study

BMJ Open

Medicine

2020

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Yue-Yun Lai

Efficacy, Safety and Pharmacokinetics of Subcutaneous Azacitidine in Chinese Patients With Higher Risk Myelodysplastic Syndromes: Results From a Multicenter, Single-Arm, Open-Label Phase 2 Study

Related publications

A 5-Day Regimen of Azacitidine for Lower-Risk Myelodysplastic Syndromes (RA or RARS): A Prospective Single-Arm Phase 2 Trial

Pharmacokinetics and Safety of Apremilast in Pediatric Patients With Moderate to Severe Plaque Psoriasis: Results From a Phase 2 Open-Label Study

Efficacy and Safety of Privigen®in Patients With Chronic Inflammatory Demyelinating Polyneuropathy: Results of a Prospective, Single-Arm, Open-Label Phase III Study (The PRIMA Study)

Pharmacokinetics, Antiviral Activity, and Safety of Rilpivirine in Pregnant Women With HIV-1 Infection: Results of a Phase 3b, Multicenter, Open-Label Study

Umbralisib Monotherapy Demonstrates Efficacy and Safety in Patients With Relapsed/Refractory Marginal Zone Lymphoma: A Multicenter, Open-Label, Registration Directed Phase 2 Study

A Phase II, Single-Arm, Open-Label, Multicenter Study to Evaluate the Efficacy and Safety of P276-00, a Cyclin-Dependent Kinase Inhibitor, in Patients With Relapsed or Refractory Mantle Cell Lymphoma

Efficacy, Safety and Population Pharmacokinetics of Sapropterin in PKU Patients <4 Years: Results From the SPARK Open-Label, Multicentre, Randomized Phase IIIb Trial

Safety and Efficacy of Azacitidine in the Treatment of Elderly Patients With Myelodysplastic Syndrome

Safety and Efficacy of Regorafenib in Patients With Treatment-Refractory Metastatic Colorectal Cancer in Turkey: The Single-Arm, Open-Label REGARD Study